Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Percutaneous Cryoablation for the Palliation of Abdominal Pain Associated With Pancreatic Cancer
Sponsor: Boston Scientific Corporation
Terminated
Low enrollment \& subjects didn't survive to study end due to cancer progression.
Other terminated trials from Boston Scientific Corporation
- Atrial Fibrillation Paroxysmal · Phase NA · Nov 2025
- Benign Prostatic Hyperplasia · Phase NA · Jul 2025
- Varicose Veins · Phase PHASE4 · Apr 2024
- Benign Biliary Strictures With Current or Prior Biliary Obstruction · Phase PHASE4 · Feb 2024
- Heart Failure NYHA Class II · Oct 2023
More terminations from Boston Scientific Corporation
This PHASE1 trial investigates Pain and Pancreatic Cancer and is currently terminated or withdrawn. Boston Scientific Corporation leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Sep 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Sep 2021 [monthly]
Terminated PHASE1
-
Jul 2020 — Jan 2021 [monthly]
Terminated PHASE1
▶ Show 3 earlier versions
-
Jun 2018 — Jul 2020 [monthly]
Terminated PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1
First recorded
Aug 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Scientific Corporation
For direct contact, visit the study record on ClinicalTrials.gov .